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Abstract
Objective To identify the risk factors for significant
depressive symptoms in people with visual impairment in
England and Wales to provide information on who is most
at risk and to whom support services could be targeted in
future.
Design A cross-sectional study using baseline data from
a pragmatic randomised controlled trial.
Setting and participants 990 participants aged 18 or
over attending 1 of 14 low-vision rehabilitation primary
care optometry-based clinics in South Wales or two
hospital clinics in London.
Outcome measure A score of ≥6 on the Geriatric
Depression Scale-15 was classed as clinically significant
depressive symptoms.
Results In a multivariable logistic regression model,
significant depressive symptoms were associated with age
(adjusted OR (AOR)=0.82, 95% CI: 0.66 to 0.90, p<0.001),
ethnicity (AOR non-white compared with white=1.72,
95% CI: 1.05 to 2.81, p=0.031), total number of eye
conditions (AOR for two vs one condition=0.98, 95% CI:
0.67 to 1.43; three or more vs one condition=0.34, 95% CI:
0.15 to 0.75, p=0.026), self-reported health (AOR for
excellent vs poor=0.01, 95% CI: 0.00 to 0.12; very good
vs poor=0.06, 95% CI: 0.03 to 0.13; good vs poor=0.14,
95% CI: 0.08 to 0.24; fair vs poor=0.28, 95% CI: 0.18
to 0.46, p<0.001) and self-reported visual functioning
(AOR=1.45, 95% CI: 1.31 to 1.61, p<0.001).
Conclusion Younger age, a non-white ethnicity, fewer
eye conditions and poorer self-reported health and
visual function are risk factors for significant depressive
symptoms in this population.
Trial registration number ISRCTN46824140; Pre-results.

Background
Vision impairment impacts on all aspects of
life and is associated with reduced functional
ability, falls, social isolation and reduced quality-of-life.1–3 There is also a growing awareness
that it has a negative impact on mental health
status too. Population-based studies provide
robust evidence of an association between
vision impairment and depression. Typically
those with a vision impairment are 2–3 times
more likely to be depressed.4 5 In Britain,

Strengths and limitations of the study
►► This is the first study of risk factors for depressive

symptoms in people seeking help for vision impairment in England and Wales.
►► It benefits from a large sample size (n=990) and a
high response rate (n=990/1323, 74.8%) which increase the generalisability of the findings.
►► It examines factors which can be readily assessed
by practitioners in primary care and general hospital clinics who come into contact with people with
vision impairment, enabling them to be alerted to
those most at risk and in need of signposting to support services.
►► However, it excludes some more difficult to measure
factors, such as vision-specific distress, coping style
and perceived social support which may also predict
depression in this population.
►► The study uses a cross-sectional design, so conclusions about direction of causality cannot be made.

for example, a large survey of >13 000 older
adults found that the prevalence of significant depressive symptoms in those with good
vision living in the community was about
4.6% while in those with a vision impairment
(<6/18) it was 13.5%.5
The prevalence of significant depressive
symptoms is also high in those accessing
rehabilitation services. Results from a study
in Australia found that when screened with
the two item Patient Health Questionnaire-2,
37% of patients attending rehabilitation
clinics or eye care services screened positive
for depressive symptoms.6 Here in the UK,
we screened over 1000 patients attending
low-vision rehabilitation appointments using
the Geriatric Depression Scale (GDS-15), as
part of the Depression in Visual Impairment
Trial (DEPVIT), a randomised controlled
trial.7 We found that 43% of patients reported
significant depressive symptoms (score ≥6)
and, significantly, 74.8% were not receiving
any treatment for depression.8 This finding
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characteristics which can be easily identified in routine
practice, for example, age and ethnicity, to provide a
straightforward approach to identifying high-risk patients
based on readily available information.

Methods
Study design and participants
This cross-sectional study was undertaken as part of
DEPVIT.7 Eligible participants were consecutive adult
patients who were seeking help for vision impairment
at specialist visual rehabilitation services taking part in
DEPVIT. Fourteen primary care-based rehabilitation
services recruited participants in South Wales. Services
were readily accessible high street practices, accepted
self-referral and tended to cater to older adults with
age-related eye conditions living in the local community. A secondary care rehabilitation clinic based at Guys
and St Thomas’ Hospital and a National Health Service
(NHS) outreach clinic providing low-vision services in
Southwark recruited participants from the London area.
Access to these two specialist clinics was by referral only.
All consecutive attendees aged 18 or over were considered eligible for the study, unless they lived outside the
catchment area for the trial or if they had previously been
screened for depression as part of the study (some people
had more than one appointment during the length of the
study, but we only wanted to screen them and invite them
to take part once). The study adhered to the Declaration
of Helsinki.
Funding and public and Patient involvement
The study was funded by Guide Dogs, a voluntary sector
organisation who work closely with people with vision
impairment and understand their experiences and preferences. They carried out a review prior to funding to
ensure the research questions were relevant and the study
design appropriate. Patients with a vision impairment
reviewed and provided feedback on the depression questionnaire. Patients were not involved in the recruitment
to or conduct of the study.
Measures
Depression
GDS-1516 is one of the most widely used instruments for
the screening of depression in older adults. The questionnaire has 15 questions, and the completion time is
approximately 5 min. Possible scores range from 0 to 15,
with higher scores indicating a greater number of depressive symptoms. We chose to use dichotomous categories
rather than the continuous scale as this reflects the scale’s
use in clinical practice as a screening tool to identify those
who warrant further investigation. We used the conventional scoring approach rather than Rasch analysis to
facilitate direct comparison with published studies and to
facilitate clinically valid results. A score of 6 or more was
taken to be indicative of significant depressive symptoms.5
Nollett C, et al. BMJ Open 2019;9:e026163. doi:10.1136/bmjopen-2018-026163
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supports previous reports that people with a vision
impairment are less likely to have their depression identified than those with good vision.9–11
Because depression goes underdetected in this patient
group, there is a need to improve routine screening.
The National Institute for Health and Care Excellence
(NICE), in their guidelines on ‘Depression in adults with
a chronic physical health problem’12 suggest that practitioners working in primary care and general hospital
clinics should be aware that patients with a chronic physical health problem, especially those with functional
impairment, are at a high risk of depression. They recommend being alert to possible depression and asking two
simple screening questions to detect depression.12 Those
screening positively should be referred to an appropriate
professional for assessment, in most cases, the patient’s
general practitioner (GP). Screening should occur in
both low-vision-specific settings such as rehabilitation
clinics, and in primary care and general clinical settings
such as diabetes or stroke clinics, where vision impairment is prevalent. In busy primary care and general
clinics, understanding who is most at risk of depression
among this patient group using easy to determine factors
may help clinicians to target depression screening and
signpost patients to supportive services.
Previous cross-sectional studies of patients from outpatient eye clinics and low-vision rehabilitation services have
identified several risk factors for depression including:
being female, being relatively younger in age, living alone
and having lower acceptance of vision loss,13 reporting
poorer self-reported health and having a history of
mental health problems,13 14 reporting poorer vision-specific functioning, higher levels of vision-specific distress,
having an avoidant coping style and lower perceived
adequacy of social support.14 A longitudinal prospective
cohort study of 540 patients from outpatient low-vision
organisations in the Netherlands and Belgium found that
people who developed depressive symptoms over a 2-year
period were more likely to be: living alone, having just
enough money to cover their expenses, have macular
degeneration, have problems with adaptation to vision
loss, have reduced health related quality of life and be
experiencing symptoms of anxiety.15
The above studies were conducted in the Netherlands,
Belgium and Australia, and we do not know if the same
risk factors apply to a British population. Therefore, it is
useful to examine the risk factors for depressive symptoms in people with sight loss in England and Wales,
using a large sample of consecutive attendees to services.
The findings will enable clinicians in primary care and
general hospital clinics to allocate resources to screening
those most at risk.
The aim of this study was to identify the risk factors
for significant depressive symptoms in people with
vision impairment attending rehabilitation clinics
in England and Wales using baseline data from a
randomised controlled trial of interventions for depression (DEPVIT).7 We focused our examination mainly on

Open access

Procedures
Participants who were eligible to take part in the study
were sent a questionnaire in large print format containing
the GDS-15, NEI-VFQ 7 and single-item question about
health, along with their appointment letter at least 1 week
before their low-vision assessment. They were asked to
complete the questionnaire at home, with assistance if
needed, and to bring it along to their appointment. Those
who did not return a completed questionnaire were given
the opportunity to complete another copy at the clinic,
before their appointment. The low-vision practitioner
reviewed the participant’s responses with them at the start
of the assessment and asked for their written consent to
use their anonymised responses in the study. For those
Nollett C, et al. BMJ Open 2019;9:e026163. doi:10.1136/bmjopen-2018-026163

who consented, information on gender, date of birth,
ethnicity, physical illness, ocular diagnosis, corrected
ETDRS LogMAR acuity and time since vision loss first
identified were recorded on a Case Report Form (CRF).
Those who screened positive for depressive symptoms
(GDS-15 score of ≥6) were offered entry to the DEPVIT
trial if eligible, or a referral to their GP if not eligible.19
CRFs completed by the clinicians were sent to the
research coordinating centre at Cardiff University by
secure fax where the validity and completeness of the
data were checked. Any missing or out of range data were
queried with the practitioner and checked with clinical
notes. Five per cent of all CRFs and surveys were double
entered. The error rate was less than 2% and identified
errors were corrected. The number of eligible patients
who did not complete the survey and the number who
did not consent for their data to be used for research
purposes were also recorded. The final dataset was then
locked and transferred to the statistical team for analysis. The descriptive statistics were tabulated using SPSS
V.23, and the regression models were fitted using STATA
V.13.1.
Statistical analysis
Participant characteristics were summarised for those
with significant depressive symptoms (GDS-15 ≥6) and
those without (GDS-15 <6). Categorical variables were
summarised as numbers and percentages and continuous
variables as medians with interquartile ranges. In all cases
we report the number of participants for whom data were
missing.
Where the GDS-15 was not fully completed, completed
answers were totalled to give a final score provided
that the number of questions not answered was two or
less.5 If three or more questions were unanswered, the
GDS-15 data were regarded as missing and the participant
excluded from the analysis.
Logistic regression was used to determine the independent relationship between each of the potential
risk factors and significant depressive symptoms. The
potential risk factors were initially included individually
(univariable analysis) and then entered into a multivariable logistic regression analyses in blocks to determine
which variables remain associated with significant depressive symptoms after controlling for the other factors. The
events-per-variable was sufficient to allow inclusion of
all potential risk factors, so no selection was required.20
However, due to co-linearity, it was not possible to include
both number and type of physical illnesses or both
number and type of eye conditions. Therefore, a decision
was made to include only number of illnesses and eye
conditions, as it was hypothesised that burden of multiple
diagnoses would be more important than type of diagnosis: those with multiple morbidity are at twice the risk of
depression than those without multiple morbidity.21 The
variables were entered into the analysis in blocks, starting
with the risk factors which could be most easily identified
in routine clinics, and ending with those requiring more
3
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Risk factors
We recorded gender, age, ethnicity (white, Asian/Asian
British, black/black British or other), physical illness
(number and type from a list of seven plus an ‘other’
category) and ocular diagnosis (number and type of eye
conditions from a list of five plus an ‘other’ category),
factors which would be readily available to clinicians
working with people with sight loss and have been considered in previous studies.
We also measured self-reported general health as this
has consistently been shown to be a risk factor for depression6 13–15 and can be easily measured using a single item
question from the SF-12, ‘In general, would you say your
overall health is: excellent, very good, good, fair or poor?’
The question has had widespread use as a single-item
measure, including in previous studies of visual impairment and depression5 14 and has shown to be significantly
and independently associated with specific health problems, use of health services, changes in functional status,
recovery from episodes of ill health, mortality and sociodemographic characteristics of respondents.17
To provide information on vision related factors for
low-vision practitioners who have access to this information, we also measured presenting corrected binocular
visual acuity using Early Treatment Diabetic Retinopathy
Study (ETDRS) LogMAR and recorded time since vision
loss in years. As previous studies have found no evidence
of an association between objective measures of visual
acuity and depression,13–15 we were interested to see
whether a subjective measure of visual function would be
associated. Self-reported visual functioning was measured
using the 7-item National Eye Institute Visual Function
Questionnaire (NEI-VFQ 7) which includes a subset of
questions from the NEI-VFQ that have previously been
shown to be responsive to rehabilitation service intervention.18 As the NEI-VFQ 7 is commonly reported in the
published literature with Rasch analysis, we transformed
the Likert responses using the Rasch derived scoring
key provided by Ryan et al18 to calculate a score for each
completed questionnaire. A higher score indicates a
greater perceived difficulty with visual functioning. Questionnaires with three or more missing items were counted
as missing and excluded from the analysis.

Open access

Results
A total of 1323 consecutive adult patients attended the
low-vision rehabilitation clinics during the 30 month
recruitment period. Of these, 312 were not screened
for depression because the practitioner felt it was inappropriate at the time (because the patient was too ill,
had dementia or was recently bereaved); or the patient
had forgotten to complete the questionnaire and there
was no time at the assessment; or they did not consent
for their data to be used for research. An additional 21
patients had three or more missing items on the GDS-15
and were excluded, leaving a final sample size of 990 and
a complete response rate of 74.8%. The median age of
the participants was 79.0 years (IQR=66.0–85.0), 62.2%
were female (n=616) and 85% were white (n=842). The
overall prevalence of significant depressive symptoms
was 42.5%. This varies very slightly from our previously
reported study (43%)8 due to the methodology used in
this study to calculate the total GDS-15 score (excluding
those with ≥3 missing items).
Tables 1–4 outline the demographic characteristics of the participants, their physical health measures,
eye health measures and self-report health and vision
measures respectively, split by those with and without
significant depressive symptoms. They also summarise
the results of the univariable logistic regression using
ORs presented with 95% CIs and p values. The variables
ethnicity, number of physical illnesses and number of eye
conditions had a small number of participants in some
categories, hence the categories were collapsed before
being entered into the regression analysis. Both the
original and collapsed categories are presented in the
tables. Table 5 Summarises the results of the multivariable logistic regression using adjusted ORs (AOR) and
are presented with 95% CIs and p values.
Demographics
Table 1 shows that those with a higher prevalence of
significant depressive symptoms were male, younger or
non-white. In the univariable analysis, age and ethnicity
were associated with significant depressive symptoms. An
increase in age was associated with lower odds of participants having depression and having ethnicity other
than white was associated with higher odds of having
depression. These variables remain associated once other
4

variables were controlled for in the multivariable analysis final model (table 5). There was no evidence of an
association between gender and significant depressive
symptoms.
Physical health
The prevalence of depression was lowest in those with no
physical illness (29.8%) and highest in those with three
or more illnesses (54.3%, table 2). In the univariable
analysis, an increase in the number of physical illnesses
was associated with higher odds of having significant
depressive symptoms. This association remained when
controlling for demographics and eye health but was no
longer associated when controlling for subjective health
and visual function.
Eye health
Those with a higher prevalence of depression had one eye
condition, worse visual acuity or less time since vision loss
(table 3). The univariable analysis found no evidence of
an association between significant depressive symptoms
and number of eye conditions, visual acuity and time
since vision loss. However, when controlling for other
factors in the final model, an increase in the number of
eye conditions was associated with lower odds of having
significant depressive symptoms.
Self-report measures
The prevalence of depression was highest in those with
poor self-rated health (81.5%) and lowest in those with
excellent health (4.3%). Those with significant depressive symptoms had worse self-rated visual functioning
(table 4). Worse self-rated health and visual functioning
were associated with higher odds of having significant
depressive symptoms in both the univariable analysis and
multivariable final model.
The area under the ROC curve was 0.59 when demographics alone were entered into the model, increasing to
0.65 when physical and eye health variables were considered and reaching 0.81 when self-report measures were
added.

Discussion
This study identified the risk factors for significant
depressive symptoms in people with vision impairment
attending vision rehabilitation clinics in England and
Wales. We focused mainly on risk factors which can be
easily identified in primary care and general hospital
clinics, so as to provide a pragmatic approach to identifying high risk patients. To inform ophthalmic clinicians
who may have access to more detailed information on
eye health, we also included a range of vision related
variables. Our findings showed that among older adults,
those of relatively younger age, with an ethnicity other
than white and poorer self-reported health and visual
function had higher odds of having significant depressive symptoms. Number of physical illnesses was an
Nollett C, et al. BMJ Open 2019;9:e026163. doi:10.1136/bmjopen-2018-026163
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time or adaptation to practice to assess. The blocks were:
(1) demographics (gender/age/ethnicity); (2) demographics and physical health (number of illnesses); (3)
demographics, physical health and eye health (number
of eye conditions/visual acuity/time since vision loss);
(4) demographics, physical health, eye health and self-report measures (self-report health/visual functioning). We
calculated the area under the Receiver Operating Characteristic (ROC) curve to quantify the overall ability of
each (additional) block of variables to correctly discriminate between those with and without depression.

22 (52.4)

Data missing, n (%)

9 (45)
0 (0)

 Other ethnic group

 Data missing

61 (41.5)
0 (0)

*Reference category.
†Collapsed categories entered instead.
GDS, Geriatric Depression Scale.

508 (60.3)

 White*

 Non-white
 Data missing

Ethnicity (collapsed), n (%)

12 (52.2)
40 (38.5)

 Asian/Asian British

 Black/black British

508 (60.3)

 White

86 (58.5)
1 (100)

334 (39.7)

1 (100)

11 (55)

64 (61.5)

11 (47.8)

334 (39.7)

20 (47.6)

77.0 (57.0, 85.0)

0

248 (40.3)

173 (46.3)

421 (42.5)

GDS-15
score ≥ 6
990

N

147
1

842

1

20

104

23

842

42

0.74 to 0.90

0.60 to 1.01

95% CI

989

2.14

1.50 to 3.06

Not entered into regression analysis†

0.82

0.78

OR

Univariable logistic regression analysis

79.0 (66.0, 85.0) 948

0

616

374

990

Total

<0.001

<0.001

0.064

P value
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Ethnicity, n (%)

0

368 (59.7)

 Female
80.0 (72.0, 86.0)

201 (53.7)

Gender, n (%)
 Male*

 Data missing

569 (57.5)

Total sample, n (%)

Age (years), median (IQR)

GDS-15 score < 6

Summary of the demographic characteristics of those with and without significant depressive symptoms

Demographic characteristics

Table 1

Open access

5
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Physical health

GDS-15
score <6

Univariable logistic regression analysis

GDS-15
score ≥6

Total

Physical illnesses*, n (%)

OR

95% CI

119 (47.8)

130 (52.2)

249

 Epilepsy

8 (57.1)

6 (42.9)

14

 Stroke

31 (50.8)

30 (49.2)

61

 Thyroid

27 (47.4)

30 (52.6)

57

 Heart disease

94 (50.3)

93 (49.7)

187

 High blood pressure

246 (55.5)

197 (44.5)

443

 Respiratory disease

48 (59.3)

33 (40.7)

81

 Other

113 (48.9)

118 (51.1)

231

 No medical illness

113 (70.2)

48 (29.8)

161

4 (100)

0 (0)

4

Total number of physical illnesses, n (%)

Not entered into regression analysis‡

 0

113 (70.2)

48 (29.8)

161

 1

277 (60.6)

180 (39.4)

457

 2

127 (48.3)

136 (51.7)

263

 3

41 (47.7)

45 (52.3)

86

 4

4 (28.6)

10 (71.4)

14

 5

2 (50)

2 (50)

4

 6

1 (100)

0 (0)

1

 Data missing

4 (100)

0 (0)

4
<0.001

Total number of physical illnesses (collapsed
categories), n (%)
 0§

113 (70.2)

48 (29.8)

161

 1

277 (60.6)

180 (39.4)

457

 2

127 (48.3)

136 (51.7)

263

48 (45.7)

57 (54.3)

105

 3 or more
 Data missing

P value

Not entered into regression analysis†

 Diabetes

 Data missing

N

4 (100)

0 (0)

986

1.53

1.04 to 2.25

2.52

1.66 to 3.82

2.8

1.68 to 4.66

4

*Participants may have had more than one physical illness.
†Not entered due to high correlation with number of physical illnesses.
‡Collapsed categories entered instead.
§Reference category.
GDS, Geriatric Depression Scale.

independent predictor of depressive symptoms, but there
was no evidence of an association when controlling for
subjective health and vision function. The number of eye
conditions was not an independent predictor of depressive symptoms, but was related to depression when other
variables were controlled: less number of eye conditions
was associated with higher odds. There was no evidence
that gender, time since vision loss and visual acuity were
associated with depression.
With regard to demographic factors, our findings
demonstrate some support for, and discrepancies with,
previous studies. In a study with an Australian population,14 a univariate analysis provided evidence that
younger age was associated with depressive symptoms,
and in a European and Australian sample (relatively)
younger age was shown to be associated with subthreshold
depression in a multivariable analysis.13 Our study corroborates these findings in a UK sample. This perhaps
6

reflects the finding in the general population that people
aged 40–59 years have higher rates of depression than
those aged ≥60 years22 and those in middle-age have the
highest risk.23 The reasons for this are not clearly understood, but one theory is that by mid-life, individuals have
learnt to adapt to their strengths and weaknesses, and in
mid-life ‘quell their infeasible aspirations’.23 In those with
vision loss, being affected in middle-age rather than old
age may add to this sense of lost aspirations and could
also result in more restriction in life including difficulties in finding and staying in work, playing sport and so
on. Our research found no evidence of an association
between gender and depressive symptoms. Previous
studies examining this association have differed in their
findings. An Australian study showed no association in a
univariate analysis,14 while a model with a European and
Australian sample found being female was a predictor of
subthreshold depression.13 The authors of a study with
Nollett C, et al. BMJ Open 2019;9:e026163. doi:10.1136/bmjopen-2018-026163
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Table 2 Summary of the physical health of those with and without significant depressive symptoms

259 (64.6)
104 (63.0)
95 (70.4)
59 (48.0)
157 (47.9)

 AMD dry

 Glaucoma

 Cataract

 Diabetic eye disease

 Other eye condition

1 (100)

32 (72.7)
2 (66.7)
0 (0)
1 (50)

 3

 4

 5

 Data missing

34 (70.8)
1 (50)
0.60 (0.40,
0.94)
0
5.5 (2.2, 12.0)
13 (81.25)

 3 or more

 Data missing

Corrected binocular visual acuity (LogMar),
median (IQR)

Data missing, n (%)

Years since vision loss, median (IQR)
Data missing, n (%)

*All ocular diagnoses—participants may have had more than one.
†Not entered due to high correlation with number of eye conditions.
‡Collapsed categories entered instead.
§Reference category.
AMD, Age-related Macular Degeneration; GDS, Geriatric Depression Scale.

107 (41.2)

153 (58.8)

 2

5.0 (2.1, 10.2)
3 (18.75)

0

0.70 (0.50, 1.00)

1 (50)

14 (29.2)

299 (44.0)

381 (56.0)

 1§

1 (50)

12 (27.3)

5.2 (2.2, 11.1)
16

0

0.67 (0.40, 1.0)

2

48

260

680

2

1

3

44

260

680

2

328

123

135

165

401

197

Total

OR

95% CI

974

990

988

0.99

1.01

0.52

0.89

0.99 to 1.01

0.99 to 1.03

0.28 to 1.00

0.67 to 1.19

Not entered into regression analysis‡

Not entered into regression analysis†

N

Univariable logistic regression analysis

0.818

0.568

0.123

P value
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Total number of eye conditions (collapsed), n (%)

1 (33.3)

153 (58.8)

107 (41.2)

381 (56)

 2

299 (44.0)

1 (50)

171 (52.1)

64 (52.0)

40 (29.6)

61 (37)

142 (35.4)

80 (40.6)

GDS-15
score ≥6

 1

Total number of eye conditions, n (%)

1 (50)

117 (59.4)

Ocular diagnosis,* n (%)
 AMD wet

 Data missing

GDS-15
score <6

Summary of the eye health of those with and without significant depressive symptoms

Eye health

Table 3

Open access

7

Open access

Self-report measures

GDS-15
score <6

GDS-15
score ≥6

Univariable logistic regression analysis
Total

N

OR

95% CI

0.01

0.00 to 0.08

0.04

0.02 to 0.07

0.09

0.05 to 0.14

0.21

0.13 to 0.32

1.48

1.36 to 1.60

Self-rated health (SF-12), n (%)
 Excellent
 Very good

<0.001
22 (95.7)

1 (4.3)

23

93 (86.1)

15 (13.9)

108

 Good

201 (72.6)

76 (27.4)

277

 Fair

192 (52.5)

174 (47.5)

366

 Poor*

33 (18.5)

145 (81.5)

178

 Data missing

28 (73.7)

10 (26.3)

38

Visual functioning†
(NEI VFQ-7), median (IQR)

P value

0.23 (-1.43, 1.46)
23 (67.6%)

1.41 (0.17, 2.49)
11 (32.4%)

Data missing n (%)

0.78

952

956

<0.001

(−0.80, 1.91)
34

*Reference category.
†NEI VFQ-7 scores have been Rasch analysed and a higher score indicates a greater perceived difficulty with visual functioning.
GDS, Geriatric Depression Scale; NEI VFQ-7, 7-item National Eye Institute Visual Function Questionnaire.

Dutch and Belgian participants reported that their findings on gender were inconclusive.15 Differences in findings across the studies may indicate this factor is country
specific, or may be due to differences in the measures
used to assess depression. For example, we included
people with all levels of depressive symptoms, whereas the
European/Australian study included only subthreshold
depression. It may be that being female is associated with
subthreshold depression but there is no association when
all levels of severity are considered. We found that having
an ethnicity other than white was a risk factor. Recent
studies on vision impairment and depression have not
measured ethnicity, however an earlier study conducted
in New Zealand found that ethnicity was not related to
depression.24 Differences between that study and ours
may be due to the different populations, with a wider
variation in ethnicities in the UK and London in particular. The New Zealand study only recorded ‘New Zealand
born European’ or ‘other’. Therefore, future studies
should include ethnicity as a variable to provide further
clarification.
There is more consistency between European and
Australasian studies and our UK study in terms of health.
We demonstrated that those with poorer self-reported
health were at much higher risk of depressive symptoms.
This confirms previous research in vision-impaired people
which has shown that poorer perceived health status,13
poorer self-reported health14 and poorer health related
quality of life24 are all predictors of depression. This is
not surprising as patients may include their emotional
health in a question about general health. Our study also
found that a higher number of physical illnesses was an
independent risk factor for depression. This is in line
with findings from the non-vision-impaired population.
A recent meta-analysis found a substantial relationship
between multimorbidity (the presence of two or more
chronic physical illnesses) and depression, reporting
that people with multimorbidity are at twice the risk of
depression to those without multimorbidity, and nearly
8

three times at risk compared with those with no chronic
physical condition.21 The authors suggest the relationship
is bidirectional and cite the Activity Restriction Model of
Depressed Affect25 which explains that multimorbidity
contributes significantly to depressive symptoms through
having to give up valued activities due to physical limitations. In our sample, the limitations of conditions such as
stroke and diabetes may have compounded any mobility
and functional issues already caused by sight loss which
can make self-care, engaging in hobbies and getting out
and about more difficult.
In terms of vision related factors, it is logical to assume
that the chances of having depressive symptoms increases
as visual acuity decreases. However, in line with other European and Australian studies,13–15 the results of the regression analysis do not support this hypothesis. What seems
to be more important is self-reported visual function:
those with worse self-reported visual function are more
at risk of depressive symptoms.26 Therefore, clinicians
should take care not to make assumptions about the likelihood of depression in only those with the lowest levels of
vision as assessed by visual acuity. The relationship is likely
to be bidirectional, with poorer visual function leading to
loss of valued activities and mood, while lowered mood
may influence a person’s perception of their vision function. As with previous studies,13 15 time since the vision
loss was first identified was also not a predictor of depression, indicating that patients may develop symptoms at
any point on their sight loss journey. The more surprising
finding was that people with three or more eye conditions
had lower odds of having significant depressive symptoms
than those with just one eye condition. On consultation with the literature, we suggest this finding may be
explained in terms of acceptance: lower acceptance of
vision loss has shown to be a predictor of subthreshold
depression.13 In their work with people with diabetic eye
disease and partial sight loss (some of whom also had
glaucoma), Oehler-Giarratana and Fitzgerald report that
patients described being in a state of ‘limbo’ where they
Nollett C, et al. BMJ Open 2019;9:e026163. doi:10.1136/bmjopen-2018-026163
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Table 4 Summary of the self-reported health and visual function of those with and without significant depressive symptoms

AOR, adjusted OR.

0.59

0.14
0.28
1.45

 Good

 Fair

Visual functioning

0.81

0.06

0.65

0.01

0.99

1.00

0.34

0.98

1.68

1.96

1.28

1.72

0.82

0.85

AOR

 Very good

0.075

0.929

0.114

<0.001

0.020

<0.001

0.462

P value

1.31 to 1.61

0.18 to 0.46

0.08 to 0.24

0.03 to 0.13

0.00 to 0.12

0.98 to 1.00

0.97 to 1.03

0.15 to 0.75

0.67 to 1.43

0.86 to 3.29

1.14 to 3.37

0.77 to 2.13

1.05 to 2.81

0.66 to 0.90

0.61 to 1.19

95% CI

Multivariable
Block 4
n=877

 Excellent

Subjective health: reference
category poor

0.98 to 1.03

1.00
0.99

Visual acuity

Time since vision loss (per
year)

0.98 to 1.00

0.24 to 0.96

0.66 to 1.27

2.27 to 7.11

2.26 to 5.78

1.36 to 3.24

1.08 to 2.40

0.74 to 0.90

0.68 to 1.19

95% CI

0.91

4.02

3.62

2.09

1.61

0.82

0.90

AOR

0.48

<0.001

0.014

<0.001

0.390

P value

 2 conditions

2.24 to 6.82

2.23 to 5.65

1.34 to 3.18

1.10 to 2.43

0.74 to 0.90

0.67 to 1.17

95% CI

Multivariable
Block 3
n=926

 3+ conditions

0.65

3.91

Total eye conditions: reference
category one condition

 3+ illnesses

1.64

3.55

0.027

2.06

1.05 to 2.27

0.82

0.89

AOR

 2 illnesses

Area under ROC curve

Self-report
measure

1.54

<0.001

0.311

P value

 1 illness

Total illnesses: reference
category 0 illness

 Non-white

0.82 to 0.90

0.66 to 1.14

95% CI

Multivariable
Block 2
n=943

<0.001

<0.001

0.244

0.942

0.026

0.051

0.031

<0.001

0.350

P value
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Eye health

Physical health

0.82

Ethnicity: reference category
white

0.87

Age (per decade)

Gender: reference category
male

Demographics

AOR

 Female

Characteristic

Multivariable
Block 1
n=947

Summary of the results of the multivariable regression analyses, with blocks of variables added sequentially to the model

Block

Table 5
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means conclusions about direction of causality are not
possible. Finally, while the completion rate of the GDS-15
was high, a number of patients were not screened at the
discretion of the practitioners, including because they felt
the patient was too ill, had dementia or had recently been
bereaved, or they did not consent for their answers be
used for research. Therefore, there may be a risk of bias as
the non-completers may be systematically different from
those that completed the questionnaire and consented
to their data being used. Similarly, we excluded cases
with missing data from the multivariable analysis and
this simple approach to missing data may have introduced some bias. However, as only 113/990 (11%) were
excluded, the risk of bias was low.
For the first time, for a population in England and
Wales, our study demonstrates that for patients with vision
impairment, there are several risk factors for depression
which can be easily identified by those coming in to
contact with people with sight loss. We recommend that
all clinicians working with people with sight loss are alert
to these factors. We advise screening higher risk patients
using the simple two question screen recommended in
the NICE guidelines.12 If a patient is identified as having
likely depression, they should be managed according to
the guidelines which includes referral to an appropriate
professional, for example, the GP. Local pathways should
be established to manage this referral. However, because
the prevalence of depressive symptoms is so high in low-vision clinics, we recommend that low-vision practitioners
introduce depression screening as part of routine care
with all patients.
Future research could include qualitative work to clarify
the pathway from the risk factors identified here to the
onset of depression, to aid the development of interventions for depression in this population.
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experienced uncertainty, fear and hope that vision might
improve.27 Perhaps surprisingly, they expressed the view
that total loss of vision would be a relief, as they could
proceed through a healing phase and make plans for
their future care. In our study, it is possible that those with
three or more eye conditions had come to terms with the
likelihood of further vision loss and reached a point of
acceptance, whereas those with one eye condition were in
the ‘limbo’ phase, with the hope that sight may improve
but the fear that it might deteriorate, and therefore not
reached this point of acceptance thus increasing their
risk of depressive symptoms. None of the studies referred
to in our introduction included number of eye conditions as a risk factor, and we could not find any studies
which included both number of eye conditions and level
of acceptance. Therefore, further research is needed to
better understand this finding and possible explanation.
Our research suggests that not all of the factors related
to depressive symptoms in people with vision impairment
are specific to that particular population. As with the
general population, age, ethnicity and health are associated with risk of depression and this needs to be taken
into consideration when understanding the link between
vision impairment and depression, and when considering
suitable interventions.
This research added to the literature by examining risk
factors in a British sample of people with vision impairment. The study benefited from a large sample size and
a high response rate, enhancing the generalisability of
the findings. As we included 14 low-vision rehabilitation
clinics across primary and secondary care, we believe the
findings are transferrable to both settings in the UK. Our
study employed validated measures of depressive symptoms and incorporated risk factors which are easy to
identify in primary care and hospital clinics. Therefore,
the results can be easily integrated in clinical practice to
target screening.
However, inevitably there were some value judgements in how we chose our criteria for selecting the
range of potential factors in our study. This means that
other parameters which have previously been shown to
be predictors of depression, for example, vision-specific
distress, lower perceived adequacy of social support and
avoidant coping,14 were not measured and therefore
cannot be included in the risk profile advice to clinicians. These parameters can only be assessed using additional questionnaires which would have increased the
overall response burden in the study, and furthermore,
it is unlikely that these variables would be measured in
routine practice and therefore were not within the scope
of our study.
We chose to dichotomise the GDS-15 to reflect how it
would be used in practice, as a screening tool for identifying patients who would benefit from screening in clinic
and potentially signposting to support services. However,
we acknowledge that this may have led to a reduction
in power and loss of information.28 A further limitation
of the study is the use of a cross-sectional design which
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